ImunoTera

  • Biotech or pharma, therapeutic R&D

ImunoTera has developed a platform of active immunotherapies that teach the immune system to recognize and eliminate cancer cells, generating a long-term memory capable of avoiding recurrences and metastases. The first product, called TERAH-7, is a therapeutic vaccine aimed at treating cancer caused by HPV, such as cervical cancer.

Address

São Paulo
São Paulo
Brazil

Website

https://www.imunotera.com.br

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS